Research Study

A Phase 3, Randomized, Double-blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of QPI-1002 for Prevention of Delayed Graft Function in Recipients of a Donation After Brain Death Older Donor Kidney Transplant
Principal Investigator 
Jagbir Gill

Overview

Body Locations and Systems 
Kidney Transplantation
Diagnosis and Therapy 
Kidney Transplantation
ClinicalTrials.gov# 
NCT02610296
Status 
Recruiting
Study Start/End 
Aug 22, 2016 to Dec 31, 2019
Locations 
St. Paul's Hospital, Vancouver General Hospital
Name/Title 
Jesmint Dhillon, Research Coordinator
Phone 
604-875-4111 ext.67679
Purpose of Study 

The purpose of this trial is to evaluate the reduction in incidence and severity of delayed graft function with kidney allografts from donors >45 years after brain death (DBD).

Eligibility 

Visit ClinicalTrials.gov for more information. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.